What’s Driving Growth in the Evenity Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Evenity Market, and What Factors Will Drive It?
In recent times, the evenity market has seen a size surge of XX (CAGR). It’s projected to expand from $XX million in 2024 to $XX million in 2025, boasting a compound annual growth rate (CAGR) of XX%. The growth during the historic period is attributable to heightened awareness about osteoporosis and fracture prevention, a higher demand for biologic drugs, an aging population, enhanced diagnostic capabilities, and an increase in the demand for bone health products.
The Evenity market is predicted to hit an XX (CAGR) over the coming years, resulting in a projected value of $XX million by 2029, with a Compound Annual Growth Rate (CAGR) of XX%. The impressive growth predicted for this forecast period is attributable to factors such as an increased approval of biologics and advanced injectables, a rise in osteoporosis cases, a surge in the number of chronic kidney disease (CKD) patients and also an escalating prevalence of rheumatoid arthritis, as well as an increase in the prevalence of comorbidities. Expectations for the future trends during the forecast period include improvements in delivery systems, the inclusion of digital health tools, the adoption of biosimilars, the introduction of innovative treatments, and advancements in diagnostic technology.
Which Factors Are Enhancing the Growth of the Evenity Market?
The growing incidence of osteoporosis is predicted to spur the expansion of the evenity market in the future. Recognized as a medical disorder, osteoporosis causes a reduction in bone density and quality, which in turn results in weaker bones susceptible to fractures. The escalating occurrence of osteoporosis can be attributed to an aging population experiencing natural bone density decline, coupled with inactive lifestyles that further compromise bone strength. Evenity is used in monthly doses for a period of up to 12 months to counter osteoporosis by enhancing bone formation, decreasing bone resorption, and making bones more robust to ward off fractures. As per a report by the UK Parliament, a UK governing body, in October 2022, osteoporotic fractures currently inflict direct costs over $5.8 billion (£4.6 billion) on the NHS, a number forecasted to touch almost $7.5 billion (£6 billion) by 2030 due to an aging populace. Consequently, the increasing incidence of osteoporosis is fostering the growth of the evenity market.
Request Your Free Evenity Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20067&type=smp
Who Are the Top Companies Contributing to the Growth of the Evenity Market?
Major companies operating in the evenity market include Amgen Inc.; UCB S.A
Secure Your Global Evenity Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/evenity-global-market-report
Which Segments of the Evenity Market Hold the Most Potential for Future Development?
The evenity market covered in this report is segmented –
1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions
What Are the Key Regions Powering Growth in the Evenity Market?
North America was the largest region in the evenity market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Defines the Scope of the Evenity Market?
Evenity (romosozumab) is a biologic medication used to treat osteoporosis in postmenopausal women at high risk of fractures by inhibiting sclerostin, promoting bone growth, and reducing bone loss. Administered through monthly subcutaneous injections, it is typically used for up to 12 months, after which other treatments may be recommended.
Browse Through More Similar Reports By The Business Research Company:
Osteoporosis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report
Postmenopausal Osteoporosis Treatment Global Market Report 2025
Osteoporosis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
